Skip to Content

M V22 (Hydrochlorothiazide and Valsartan 12.5 mg / 160 mg)

Pill with imprint M V22 is Orange, Round and has been identified as Hydrochlorothiazide and Valsartan 12.5 mg / 160 mg. It is supplied by Mylan Pharmaceuticals Inc..

Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 12.5 mg / 160 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M V22

Hydrochlorothiazide and valsartan 12.5 mg / 160 mg M V22
Hydrochlorothiazide and valsartan 12.5 mg / 160 mg M V22
Hydrochlorothiazide and valsartan 12.5 mg / 160 mg M V22

Hydrochlorothiazide and Valsartan

Imprint
M V22
Strength
12.5 mg / 160 mg
Color
Orange
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin II inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, hypromelloses, ferric oxide red, lactose monohydrate, magnesium stearate, ferric oxide yellow, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, corn starch, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-6322 Mylan Pharmaceuticals Inc.
51079-0193 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.